Anti-Cancer Treatment - 12th International Congress: 4-7 February 2002, Paris, France

Edith A. Perez

Research output: Contribution to journalArticle

Abstract

The 12th ICACT meeting was excellent in reviewing state-of-the-art management approaches to patients with cancer, and was also outstanding in presenting the rationale and background for many worldwide studies incorporating novel therapeutic approaches. The meeting also set the platform for understanding the mechanisms behind new therapeutic targets being used alone, or most likely in combination with existing therapies, and discussed the implications of their use in ongoing phase I, II, and trials.

Original languageEnglish (US)
Pages (from-to)222-223
Number of pages2
JournalIDrugs
Volume5
Issue number3
StatePublished - 2002

Fingerprint

Paris
France
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Pharmacology

Cite this

Anti-Cancer Treatment - 12th International Congress : 4-7 February 2002, Paris, France. / Perez, Edith A.

In: IDrugs, Vol. 5, No. 3, 2002, p. 222-223.

Research output: Contribution to journalArticle

@article{cb0d6ecf5b38497b9fb2b12d28ed390d,
title = "Anti-Cancer Treatment - 12th International Congress: 4-7 February 2002, Paris, France",
abstract = "The 12th ICACT meeting was excellent in reviewing state-of-the-art management approaches to patients with cancer, and was also outstanding in presenting the rationale and background for many worldwide studies incorporating novel therapeutic approaches. The meeting also set the platform for understanding the mechanisms behind new therapeutic targets being used alone, or most likely in combination with existing therapies, and discussed the implications of their use in ongoing phase I, II, and trials.",
author = "Perez, {Edith A.}",
year = "2002",
language = "English (US)",
volume = "5",
pages = "222--223",
journal = "IDrugs : the investigational drugs journal",
issn = "1369-7056",
publisher = "Current Drugs Ltd.",
number = "3",

}

TY - JOUR

T1 - Anti-Cancer Treatment - 12th International Congress

T2 - 4-7 February 2002, Paris, France

AU - Perez, Edith A.

PY - 2002

Y1 - 2002

N2 - The 12th ICACT meeting was excellent in reviewing state-of-the-art management approaches to patients with cancer, and was also outstanding in presenting the rationale and background for many worldwide studies incorporating novel therapeutic approaches. The meeting also set the platform for understanding the mechanisms behind new therapeutic targets being used alone, or most likely in combination with existing therapies, and discussed the implications of their use in ongoing phase I, II, and trials.

AB - The 12th ICACT meeting was excellent in reviewing state-of-the-art management approaches to patients with cancer, and was also outstanding in presenting the rationale and background for many worldwide studies incorporating novel therapeutic approaches. The meeting also set the platform for understanding the mechanisms behind new therapeutic targets being used alone, or most likely in combination with existing therapies, and discussed the implications of their use in ongoing phase I, II, and trials.

UR - http://www.scopus.com/inward/record.url?scp=0141784084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141784084&partnerID=8YFLogxK

M3 - Article

C2 - 15562331

AN - SCOPUS:0141784084

VL - 5

SP - 222

EP - 223

JO - IDrugs : the investigational drugs journal

JF - IDrugs : the investigational drugs journal

SN - 1369-7056

IS - 3

ER -